BIOCON:NSE
Biocon Ltd
349,20 ₹
arrow_downward
-0,80%(-2,80) 1D
16 tet, 3:30:00 m.d., GMT+5:30 · INR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për BIOCON...
Hap
352,60 ₹
I lartë
353,00 ₹
I ulët
348,00 ₹
Kapitalizimi i tregut
568,79Â mld
Vëllimi mesatar
2,97Â mln
Vëllimi
1,88Â mln
Dividendi
0,14%
Dividendi tremujor
0,12 ₹
Data e ndërprerjes së dividendit
3 korr 2026
Raporti çmim/fitim
103,38
Maksimumi 52-javor
447,15 ₹
Minimumi 52-javor
337,70 ₹
Fitimet për aksion
3,38 ₹
Aksionet në qarkullim
600,00Â mln
Numri i punonjësve
16 mijë
Hap
352,60 ₹
I lartë
353,00 ₹
I ulët
348,00 ₹
Kapitalizimi i tregut
568,79Â mld
Vëllimi mesatar
2,97Â mln
Vëllimi
1,88Â mln
Dividendi
0,14%
Dividendi tremujor
0,12 ₹
Data e ndërprerjes së dividendit
3 korr 2026
Raporti çmim/fitim
103,38
Maksimumi 52-javor
447,15 ₹
Minimumi 52-javor
337,70 ₹
Fitimet për aksion
3,38 ₹
Aksionet në qarkullim
600,00Â mln
Numri i punonjësve
16 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
MarketBeat
·
18 minuta më parë
Ideal Power (NASDAQ:IPWR) Stock Breaks Below Two Hundred Day Moving Average - What's Next?
BigGo Finance
·
1 orë më parë
AI investment logic shifts and chip sell-off hit markets: Nasdaq tumbles 2.15%, Philadelphia Semiconductor Index plunges 3.83%
MarketBeat
·
1 orë më parë
Red Rock Resorts, Inc. (NASDAQ:RRR) Stock Has Consensus Target Price of $71.94
CNN
·
12 orë më parë
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profili
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Rreth Biocon Ltd
Drejtori ekzekutivShreehas P Tambe
Punonjësit16,4 mijë
Themeluar më29 nën 1978
SeliaBangalore, Karnataka, Indi
Sektori-
Uebsajtibiocon.com